Home / Business News / English News / PE firm Advent acquires 50.1% stake in Suven Pharma at Rs 495/share, to make open offer for additional 26% stake
Published on: September 29, 2023 4:44 PM | Source: Business Today | Latest Stock Market And Economy News India
Advent also announced the new Board of Directors and management team for Suven Pharma, including Sudhir Kumar Singh as CEO
